PYC Therapeutics (ASX:PYC) Total Equity: A$147.33 Mil (As of Dec. 2025)


ASX:PYC PYC Therapeutics Ltd ASX:PYC
35 GF Score
Price A$1.54
! 2 Warning Signs
View Full Analysis

What is PYC Therapeutics Total Equity?

PYC Therapeutics ASX:PYC 35 Total Equity is A$147.33 Mil as of Dec. 2025. GuruFocus rates ASX:PYC with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

PYC Therapeutics's total equity for the quarter that ended in Dec. 2025 was A$147.33 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

PYC Therapeutics Total Equity Historical Data

* Premium members only.

The historical data trend for PYC Therapeutics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PYC Therapeutics Total Equity Chart

PYC Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.92 40.20 28.44 81.06 170.01

PYC Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.69 81.06 55.70 170.01 147.33
ASX:PYC
35GF Score
PYC Therapeutics Ltd ASX:PYC
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PYC Therapeutics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PYC Therapeutics's Total Equity for the fiscal year that ended in Jun. 2025 is calculated as

Total Equity=Total Assets(Q: Jun. 2025 )-Total Liabilities(Q: Jun. 2025 )
=183.279-13.271
=170.01

PYC Therapeutics's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=159.13-11.802
=147.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of A$147.33 Mil mean?
PYC Therapeutics (ASX:PYC) has a Total Equity of A$147.33 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for PYC Therapeutics and its competitors.
Is PYC Therapeutics' Total Equity too high?
PYC Therapeutics' current Total Equity is A$147.33 Mil. Overall, PYC Therapeutics has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PYC Therapeutics' Total Equity compare to VRTX and REGN?
PYC Therapeutics' Total Equity of A$147.33 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for PYC Therapeutics and its competitors. PYC Therapeutics's current Total Equity is A$147.33 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PYC Therapeutics stock overvalued right now?
PYC Therapeutics (ASX:PYC) has a current Total Equity of A$147.33 Mil. The current Total Equity is A$147.33 Mil. PYC Therapeutics' overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For PYC Therapeutics (ASX:PYC), the current Total Equity is A$147.33 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PYC Therapeutics Business Description

Other Exchanges PYCXF:USA
Address 6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
35GF Score

Get the complete analysis for ASX:PYC

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.54
Price